nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—CYP11B2—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.0157	0.0672	CbGpPWpGaD
Eplerenone—CYP3A4—Thiotepa—urinary bladder cancer	0.00909	0.465	CbGbCtD
Eplerenone—NR3C2—Preimplantation Embryo—AQP3—urinary bladder cancer	0.00829	0.0356	CbGpPWpGaD
Eplerenone—NR3C2—Preimplantation Embryo—CDX2—urinary bladder cancer	0.00795	0.0341	CbGpPWpGaD
Eplerenone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00752	0.0322	CbGpPWpGaD
Eplerenone—CYP11B2—renal system—urinary bladder cancer	0.00744	0.149	CbGeAlD
Eplerenone—CYP11B2—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00742	0.0318	CbGpPWpGaD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00665	0.0285	CbGpPWpGaD
Eplerenone—CYP3A5—Etoposide—urinary bladder cancer	0.00632	0.323	CbGbCtD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00609	0.0261	CbGpPWpGaD
Eplerenone—CYP3A4—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00596	0.0256	CbGpPWpGaD
Eplerenone—CYP3A5—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00593	0.0254	CbGpPWpGaD
Eplerenone—CYP3A4—urine—urinary bladder cancer	0.00544	0.109	CbGeAlD
Eplerenone—NR3C2—prostate gland—urinary bladder cancer	0.00481	0.0967	CbGeAlD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00481	0.0206	CbGpPWpGaD
Eplerenone—NR3C2—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.00446	0.0191	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—GSTZ1—urinary bladder cancer	0.00415	0.0178	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00409	0.0175	CbGpPWpGaD
Eplerenone—NR3C2—seminal vesicle—urinary bladder cancer	0.00407	0.0818	CbGeAlD
Eplerenone—CYP11B2—Biological oxidations—GSTO2—urinary bladder cancer	0.00393	0.0169	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—NAT1—urinary bladder cancer	0.00393	0.0169	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00388	0.0166	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—UGT2B7—urinary bladder cancer	0.0036	0.0154	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00355	0.0152	CbGpPWpGaD
Eplerenone—CYP11B2—lymph node—urinary bladder cancer	0.00348	0.07	CbGeAlD
Eplerenone—NR3C2—smooth muscle tissue—urinary bladder cancer	0.00341	0.0685	CbGeAlD
Eplerenone—NR3C2—renal system—urinary bladder cancer	0.00328	0.0659	CbGeAlD
Eplerenone—CYP11B2—Biological oxidations—CYP4B1—urinary bladder cancer	0.00324	0.0139	CbGpPWpGaD
Eplerenone—NR3C2—urethra—urinary bladder cancer	0.00322	0.0648	CbGeAlD
Eplerenone—CYP11B2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00319	0.0137	CbGpPWpGaD
Eplerenone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00319	0.0137	CbGpPWpGaD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00315	0.0135	CbGpPWpGaD
Eplerenone—CYP3A4—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.00312	0.0134	CbGpPWpGaD
Eplerenone—CYP3A4—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00276	0.0118	CbGpPWpGaD
Eplerenone—NR3C2—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.0027	0.0116	CbGpPWpGaD
Eplerenone—NR3C2—female reproductive system—urinary bladder cancer	0.00263	0.0528	CbGeAlD
Eplerenone—CYP3A5—prostate gland—urinary bladder cancer	0.0026	0.0523	CbGeAlD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00258	0.0111	CbGpPWpGaD
Eplerenone—NR3C2—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.00247	0.0106	CbGpPWpGaD
Eplerenone—CYP3A4—Etoposide—urinary bladder cancer	0.00247	0.126	CbGbCtD
Eplerenone—NR3C2—vagina—urinary bladder cancer	0.00238	0.0478	CbGeAlD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.0023	0.00988	CbGpPWpGaD
Eplerenone—Fluoxymesterone—ESR1—urinary bladder cancer	0.00227	0.334	CrCbGaD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00227	0.00975	CbGpPWpGaD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00224	0.00958	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—NAT2—urinary bladder cancer	0.00215	0.00923	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00212	0.00911	CbGpPWpGaD
Eplerenone—NR3C2—Preimplantation Embryo—CDH1—urinary bladder cancer	0.00212	0.0091	CbGpPWpGaD
Eplerenone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.00196	0.00842	CbGpPWpGaD
Eplerenone—Medroxyprogesterone Acetate—ESR1—urinary bladder cancer	0.00195	0.286	CrCbGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00187	0.00801	CbGpPWpGaD
Eplerenone—CYP3A5—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.00186	0.00798	CbGpPWpGaD
Eplerenone—CYP3A5—renal system—urinary bladder cancer	0.00177	0.0356	CbGeAlD
Eplerenone—CYP3A7—Biological oxidations—GSTZ1—urinary bladder cancer	0.00176	0.00754	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00173	0.00744	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—HPGDS—urinary bladder cancer	0.00172	0.00738	CbGpPWpGaD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.00169	0.00724	CbGpPWpGaD
Eplerenone—CYP3A4—Doxorubicin—urinary bladder cancer	0.00168	0.0859	CbGbCtD
Eplerenone—CYP11B2—Biological oxidations—GSTT1—urinary bladder cancer	0.00167	0.00716	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—GSTO2—urinary bladder cancer	0.00167	0.00715	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—NAT1—urinary bladder cancer	0.00167	0.00715	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00164	0.00705	CbGpPWpGaD
Eplerenone—NR3C2—lymph node—urinary bladder cancer	0.00154	0.0309	CbGeAlD
Eplerenone—CYP3A7—Biological oxidations—UGT2B7—urinary bladder cancer	0.00152	0.00654	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.0015	0.00645	CbGpPWpGaD
Eplerenone—Drospirenone—PTGS2—urinary bladder cancer	0.00146	0.214	CrCbGaD
Eplerenone—CYP3A7—Biological oxidations—CYP4B1—urinary bladder cancer	0.00137	0.00589	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00135	0.0058	CbGpPWpGaD
Eplerenone—CYP3A4—renal system—urinary bladder cancer	0.00133	0.0267	CbGeAlD
Eplerenone—CYP3A5—vagina—urinary bladder cancer	0.00128	0.0258	CbGeAlD
Eplerenone—CYP3A5—Biological oxidations—GSTZ1—urinary bladder cancer	0.00127	0.00545	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00125	0.00538	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00124	0.00533	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GSTO2—urinary bladder cancer	0.00121	0.00517	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—NAT1—urinary bladder cancer	0.00121	0.00517	CbGpPWpGaD
Eplerenone—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.0012	0.00516	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00119	0.0051	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—GSTP1—urinary bladder cancer	0.00116	0.00496	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00114	0.00489	CbGpPWpGaD
Eplerenone—Progesterone—ESR1—urinary bladder cancer	0.00113	0.165	CrCbGaD
Eplerenone—CYP3A5—Biological oxidations—UGT2B7—urinary bladder cancer	0.0011	0.00473	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00109	0.00466	CbGpPWpGaD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00107	0.00459	CbGpPWpGaD
Eplerenone—CYP3A4—female reproductive system—urinary bladder cancer	0.00107	0.0214	CbGeAlD
Eplerenone—CYP11B2—Biological oxidations—GSTM1—urinary bladder cancer	0.00106	0.00456	CbGpPWpGaD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00106	0.00453	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00105	0.0045	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—CYP4B1—urinary bladder cancer	0.000992	0.00425	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000979	0.0042	CbGpPWpGaD
Eplerenone—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000922	0.00395	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—NAT2—urinary bladder cancer	0.000913	0.00392	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000901	0.00386	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000869	0.00372	CbGpPWpGaD
Eplerenone—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000865	0.00371	CbGpPWpGaD
Eplerenone—Dehydration—Doxorubicin—urinary bladder cancer	0.000772	0.00112	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.00077	0.0033	CbGpPWpGaD
Eplerenone—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.00077	0.00111	CcSEcCtD
Eplerenone—Eosinophilia—Epirubicin—urinary bladder cancer	0.000767	0.00111	CcSEcCtD
Eplerenone—Dyspnoea—Cisplatin—urinary bladder cancer	0.000765	0.00111	CcSEcCtD
Eplerenone—Skin disorder—Etoposide—urinary bladder cancer	0.000764	0.00111	CcSEcCtD
Eplerenone—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00076	0.0011	CcSEcCtD
Eplerenone—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000759	0.0011	CcSEcCtD
Eplerenone—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000758	0.0011	CcSEcCtD
Eplerenone—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.000755	0.00109	CcSEcCtD
Eplerenone—Angina pectoris—Epirubicin—urinary bladder cancer	0.000755	0.00109	CcSEcCtD
Eplerenone—Diarrhoea—Thiotepa—urinary bladder cancer	0.000749	0.00108	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000747	0.00108	CcSEcCtD
Eplerenone—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000746	0.00108	CcSEcCtD
Eplerenone—Bronchitis—Epirubicin—urinary bladder cancer	0.000745	0.00108	CcSEcCtD
Eplerenone—Pneumonia—Methotrexate—urinary bladder cancer	0.000743	0.00108	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000741	0.00107	CcSEcCtD
Eplerenone—Infestation—Methotrexate—urinary bladder cancer	0.000738	0.00107	CcSEcCtD
Eplerenone—Infestation NOS—Methotrexate—urinary bladder cancer	0.000738	0.00107	CcSEcCtD
Eplerenone—Depression—Methotrexate—urinary bladder cancer	0.000736	0.00107	CcSEcCtD
Eplerenone—Hypotension—Etoposide—urinary bladder cancer	0.000735	0.00106	CcSEcCtD
Eplerenone—Pain—Cisplatin—urinary bladder cancer	0.000734	0.00106	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000732	0.00106	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—HPGDS—urinary bladder cancer	0.00073	0.00313	CbGpPWpGaD
Eplerenone—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000728	0.00105	CcSEcCtD
Eplerenone—Renal failure—Methotrexate—urinary bladder cancer	0.000726	0.00105	CcSEcCtD
Eplerenone—Dizziness—Thiotepa—urinary bladder cancer	0.000724	0.00105	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.00072	0.00104	CcSEcCtD
Eplerenone—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000716	0.00104	CcSEcCtD
Eplerenone—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00071	0.00103	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—GSTZ1—urinary bladder cancer	0.000709	0.00304	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—GSTT1—urinary bladder cancer	0.000708	0.00304	CbGpPWpGaD
Eplerenone—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000707	0.00102	CcSEcCtD
Eplerenone—Haematuria—Methotrexate—urinary bladder cancer	0.000704	0.00102	CcSEcCtD
Eplerenone—Dyspnoea—Etoposide—urinary bladder cancer	0.000701	0.00101	CcSEcCtD
Eplerenone—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000699	0.00101	CcSEcCtD
Eplerenone—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000699	0.00101	CcSEcCtD
Eplerenone—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000698	0.00101	CcSEcCtD
Eplerenone—Vomiting—Thiotepa—urinary bladder cancer	0.000696	0.00101	CcSEcCtD
Eplerenone—Pneumonia—Epirubicin—urinary bladder cancer	0.000695	0.00101	CcSEcCtD
Eplerenone—Infestation NOS—Epirubicin—urinary bladder cancer	0.000691	0.001	CcSEcCtD
Eplerenone—Infestation—Epirubicin—urinary bladder cancer	0.000691	0.001	CcSEcCtD
Eplerenone—Rash—Thiotepa—urinary bladder cancer	0.00069	0.000999	CcSEcCtD
Eplerenone—Bronchitis—Doxorubicin—urinary bladder cancer	0.00069	0.000999	CcSEcCtD
Eplerenone—Dermatitis—Thiotepa—urinary bladder cancer	0.000689	0.000998	CcSEcCtD
Eplerenone—Headache—Thiotepa—urinary bladder cancer	0.000686	0.000993	CcSEcCtD
Eplerenone—Renal failure—Epirubicin—urinary bladder cancer	0.000679	0.000984	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000679	0.000983	CcSEcCtD
Eplerenone—Body temperature increased—Cisplatin—urinary bladder cancer	0.000678	0.000982	CcSEcCtD
Eplerenone—Fatigue—Etoposide—urinary bladder cancer	0.000678	0.000982	CcSEcCtD
Eplerenone—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000677	0.000981	CcSEcCtD
Eplerenone—Pain—Etoposide—urinary bladder cancer	0.000672	0.000974	CcSEcCtD
Eplerenone—Constipation—Etoposide—urinary bladder cancer	0.000672	0.000974	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—GSTO2—urinary bladder cancer	0.000672	0.00288	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NAT1—urinary bladder cancer	0.000672	0.00288	CbGpPWpGaD
Eplerenone—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000672	0.000973	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000666	0.000965	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000661	0.00283	CbGpPWpGaD
Eplerenone—Asthenia—Gemcitabine—urinary bladder cancer	0.000661	0.000957	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—NAT2—urinary bladder cancer	0.00066	0.00283	CbGpPWpGaD
Eplerenone—Haematuria—Epirubicin—urinary bladder cancer	0.000659	0.000954	CcSEcCtD
Eplerenone—Pharyngitis—Methotrexate—urinary bladder cancer	0.000658	0.000953	CcSEcCtD
Eplerenone—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000655	0.000948	CcSEcCtD
Eplerenone—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000654	0.000946	CcSEcCtD
Eplerenone—Pruritus—Gemcitabine—urinary bladder cancer	0.000651	0.000943	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000651	0.00279	CbGpPWpGaD
Eplerenone—Nausea—Thiotepa—urinary bladder cancer	0.00065	0.000941	CcSEcCtD
Eplerenone—Urethral disorder—Methotrexate—urinary bladder cancer	0.00065	0.000941	CcSEcCtD
Eplerenone—Feeling abnormal—Etoposide—urinary bladder cancer	0.000648	0.000938	CcSEcCtD
Eplerenone—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000647	0.000937	CcSEcCtD
Eplerenone—Pneumonia—Doxorubicin—urinary bladder cancer	0.000643	0.000931	CcSEcCtD
Eplerenone—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000643	0.000931	CcSEcCtD
Eplerenone—Pruritus—Fluorouracil—urinary bladder cancer	0.00064	0.000927	CcSEcCtD
Eplerenone—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000639	0.000926	CcSEcCtD
Eplerenone—Infestation—Doxorubicin—urinary bladder cancer	0.000639	0.000926	CcSEcCtD
Eplerenone—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00063	0.000912	CcSEcCtD
Eplerenone—Renal failure—Doxorubicin—urinary bladder cancer	0.000629	0.00091	CcSEcCtD
Eplerenone—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000627	0.000908	CcSEcCtD
Eplerenone—Abdominal pain—Etoposide—urinary bladder cancer	0.000622	0.0009	CcSEcCtD
Eplerenone—Body temperature increased—Etoposide—urinary bladder cancer	0.000622	0.0009	CcSEcCtD
Eplerenone—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000621	0.0009	CcSEcCtD
Eplerenone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000619	0.000897	CcSEcCtD
Eplerenone—Tinnitus—Methotrexate—urinary bladder cancer	0.000618	0.000895	CcSEcCtD
Eplerenone—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000617	0.000894	CcSEcCtD
Eplerenone—Asthenia—Cisplatin—urinary bladder cancer	0.000616	0.000892	CcSEcCtD
Eplerenone—Pharyngitis—Epirubicin—urinary bladder cancer	0.000616	0.000892	CcSEcCtD
Eplerenone—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000615	0.000891	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—UGT2B7—urinary bladder cancer	0.000615	0.00264	CbGpPWpGaD
Eplerenone—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000613	0.000887	CcSEcCtD
Eplerenone—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000611	0.000885	CcSEcCtD
Eplerenone—Haematuria—Doxorubicin—urinary bladder cancer	0.00061	0.000883	CcSEcCtD
Eplerenone—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00061	0.000883	CcSEcCtD
Eplerenone—Urethral disorder—Epirubicin—urinary bladder cancer	0.000608	0.000881	CcSEcCtD
Eplerenone—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000605	0.000876	CcSEcCtD
Eplerenone—Angiopathy—Methotrexate—urinary bladder cancer	0.000601	0.000871	CcSEcCtD
Eplerenone—Dizziness—Fluorouracil—urinary bladder cancer	0.000599	0.000867	CcSEcCtD
Eplerenone—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000597	0.000865	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000594	0.00255	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000591	0.00253	CbGpPWpGaD
Eplerenone—Diarrhoea—Cisplatin—urinary bladder cancer	0.000587	0.00085	CcSEcCtD
Eplerenone—Vomiting—Gemcitabine—urinary bladder cancer	0.000585	0.000848	CcSEcCtD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000583	0.0025	CbGpPWpGaD
Eplerenone—Mental disorder—Methotrexate—urinary bladder cancer	0.000581	0.000841	CcSEcCtD
Eplerenone—Rash—Gemcitabine—urinary bladder cancer	0.000581	0.000841	CcSEcCtD
Eplerenone—Dermatitis—Gemcitabine—urinary bladder cancer	0.00058	0.00084	CcSEcCtD
Eplerenone—Tinnitus—Epirubicin—urinary bladder cancer	0.000578	0.000837	CcSEcCtD
Eplerenone—Malnutrition—Methotrexate—urinary bladder cancer	0.000577	0.000836	CcSEcCtD
Eplerenone—Headache—Gemcitabine—urinary bladder cancer	0.000577	0.000835	CcSEcCtD
Eplerenone—Flushing—Epirubicin—urinary bladder cancer	0.000576	0.000834	CcSEcCtD
Eplerenone—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000576	0.000834	CcSEcCtD
Eplerenone—Vomiting—Fluorouracil—urinary bladder cancer	0.000576	0.000833	CcSEcCtD
Eplerenone—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000571	0.000827	CcSEcCtD
Eplerenone—Rash—Fluorouracil—urinary bladder cancer	0.000571	0.000827	CcSEcCtD
Eplerenone—Dermatitis—Fluorouracil—urinary bladder cancer	0.00057	0.000826	CcSEcCtD
Eplerenone—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00057	0.000825	CcSEcCtD
Eplerenone—Headache—Fluorouracil—urinary bladder cancer	0.000567	0.000821	CcSEcCtD
Eplerenone—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000567	0.000821	CcSEcCtD
Eplerenone—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000565	0.000819	CcSEcCtD
Eplerenone—Asthenia—Etoposide—urinary bladder cancer	0.000564	0.000817	CcSEcCtD
Eplerenone—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000564	0.000817	CcSEcCtD
Eplerenone—Angiopathy—Epirubicin—urinary bladder cancer	0.000563	0.000815	CcSEcCtD
Eplerenone—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000563	0.000815	CcSEcCtD
Eplerenone—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.00056	0.0024	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.00056	0.0024	CbGpPWpGaD
Eplerenone—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000559	0.00081	CcSEcCtD
Eplerenone—Back pain—Methotrexate—urinary bladder cancer	0.000558	0.000808	CcSEcCtD
Eplerenone—Pruritus—Etoposide—urinary bladder cancer	0.000556	0.000805	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—CYP4B1—urinary bladder cancer	0.000554	0.00237	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000553	0.00237	CbGpPWpGaD
Eplerenone—Nausea—Gemcitabine—urinary bladder cancer	0.000547	0.000792	CcSEcCtD
Eplerenone—Vomiting—Cisplatin—urinary bladder cancer	0.000546	0.00079	CcSEcCtD
Eplerenone—Mental disorder—Epirubicin—urinary bladder cancer	0.000543	0.000787	CcSEcCtD
Eplerenone—Rash—Cisplatin—urinary bladder cancer	0.000541	0.000784	CcSEcCtD
Eplerenone—Dermatitis—Cisplatin—urinary bladder cancer	0.000541	0.000783	CcSEcCtD
Eplerenone—Malnutrition—Epirubicin—urinary bladder cancer	0.00054	0.000782	CcSEcCtD
Eplerenone—Diarrhoea—Etoposide—urinary bladder cancer	0.000538	0.000779	CcSEcCtD
Eplerenone—Nausea—Fluorouracil—urinary bladder cancer	0.000538	0.000779	CcSEcCtD
Eplerenone—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000535	0.000775	CcSEcCtD
Eplerenone—Tinnitus—Doxorubicin—urinary bladder cancer	0.000535	0.000775	CcSEcCtD
Eplerenone—Anaemia—Methotrexate—urinary bladder cancer	0.000533	0.000772	CcSEcCtD
Eplerenone—Flushing—Doxorubicin—urinary bladder cancer	0.000533	0.000771	CcSEcCtD
Eplerenone—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000533	0.000771	CcSEcCtD
Eplerenone—Flatulence—Epirubicin—urinary bladder cancer	0.000532	0.000771	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—HPGDS—urinary bladder cancer	0.000528	0.00226	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—SLC19A1—urinary bladder cancer	0.000523	0.00224	CbGpPWpGaD
Eplerenone—Back pain—Epirubicin—urinary bladder cancer	0.000522	0.000756	CcSEcCtD
Eplerenone—Angiopathy—Doxorubicin—urinary bladder cancer	0.000521	0.000754	CcSEcCtD
Eplerenone—Malaise—Methotrexate—urinary bladder cancer	0.00052	0.000753	CcSEcCtD
Eplerenone—Dizziness—Etoposide—urinary bladder cancer	0.00052	0.000753	CcSEcCtD
Eplerenone—Muscle spasms—Epirubicin—urinary bladder cancer	0.000519	0.000752	CcSEcCtD
Eplerenone—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000517	0.000749	CcSEcCtD
Eplerenone—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000512	0.0022	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GSTT1—urinary bladder cancer	0.000512	0.00219	CbGpPWpGaD
Eplerenone—Nausea—Cisplatin—urinary bladder cancer	0.00051	0.000738	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—PRSS3—urinary bladder cancer	0.000509	0.00218	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000505	0.00217	CbGpPWpGaD
Eplerenone—Cough—Methotrexate—urinary bladder cancer	0.000504	0.000729	CcSEcCtD
Eplerenone—Mental disorder—Doxorubicin—urinary bladder cancer	0.000503	0.000728	CcSEcCtD
Eplerenone—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000501	0.000726	CcSEcCtD
Eplerenone—Vomiting—Etoposide—urinary bladder cancer	0.0005	0.000724	CcSEcCtD
Eplerenone—Malnutrition—Doxorubicin—urinary bladder cancer	0.0005	0.000724	CcSEcCtD
Eplerenone—Anaemia—Epirubicin—urinary bladder cancer	0.000499	0.000723	CcSEcCtD
Eplerenone—Rash—Etoposide—urinary bladder cancer	0.000496	0.000718	CcSEcCtD
Eplerenone—Dermatitis—Etoposide—urinary bladder cancer	0.000495	0.000717	CcSEcCtD
Eplerenone—Headache—Etoposide—urinary bladder cancer	0.000493	0.000713	CcSEcCtD
Eplerenone—Flatulence—Doxorubicin—urinary bladder cancer	0.000492	0.000713	CcSEcCtD
Eplerenone—Myalgia—Methotrexate—urinary bladder cancer	0.000491	0.000711	CcSEcCtD
Eplerenone—Chest pain—Methotrexate—urinary bladder cancer	0.000491	0.000711	CcSEcCtD
Eplerenone—Arthralgia—Methotrexate—urinary bladder cancer	0.000491	0.000711	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—GSTP1—urinary bladder cancer	0.000491	0.0021	CbGpPWpGaD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000488	0.000706	CcSEcCtD
Eplerenone—Malaise—Epirubicin—urinary bladder cancer	0.000487	0.000705	CcSEcCtD
Eplerenone—Discomfort—Methotrexate—urinary bladder cancer	0.000485	0.000703	CcSEcCtD
Eplerenone—Syncope—Epirubicin—urinary bladder cancer	0.000484	0.000701	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000484	0.00208	CbGpPWpGaD
Eplerenone—Back pain—Doxorubicin—urinary bladder cancer	0.000483	0.0007	CcSEcCtD
Eplerenone—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00048	0.000696	CcSEcCtD
Eplerenone—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000475	0.000687	CcSEcCtD
Eplerenone—Cough—Epirubicin—urinary bladder cancer	0.000471	0.000682	CcSEcCtD
Eplerenone—Infection—Methotrexate—urinary bladder cancer	0.000468	0.000677	CcSEcCtD
Eplerenone—Nausea—Etoposide—urinary bladder cancer	0.000467	0.000676	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000467	0.002	CbGpPWpGaD
Eplerenone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000464	0.000671	CcSEcCtD
Eplerenone—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000462	0.000669	CcSEcCtD
Eplerenone—Anaemia—Doxorubicin—urinary bladder cancer	0.000462	0.000669	CcSEcCtD
Eplerenone—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000461	0.00198	CbGpPWpGaD
Eplerenone—Chest pain—Epirubicin—urinary bladder cancer	0.00046	0.000666	CcSEcCtD
Eplerenone—Myalgia—Epirubicin—urinary bladder cancer	0.00046	0.000666	CcSEcCtD
Eplerenone—Arthralgia—Epirubicin—urinary bladder cancer	0.00046	0.000666	CcSEcCtD
Eplerenone—Skin disorder—Methotrexate—urinary bladder cancer	0.000457	0.000662	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000457	0.000661	CcSEcCtD
Eplerenone—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000455	0.000659	CcSEcCtD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000455	0.00195	CbGpPWpGaD
Eplerenone—Discomfort—Epirubicin—urinary bladder cancer	0.000454	0.000658	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—GSTM1—urinary bladder cancer	0.000451	0.00193	CbGpPWpGaD
Eplerenone—Malaise—Doxorubicin—urinary bladder cancer	0.000451	0.000652	CcSEcCtD
Eplerenone—Syncope—Doxorubicin—urinary bladder cancer	0.000448	0.000649	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000445	0.00191	CbGpPWpGaD
Eplerenone—Hypotension—Methotrexate—urinary bladder cancer	0.00044	0.000637	CcSEcCtD
Eplerenone—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000439	0.000636	CcSEcCtD
Eplerenone—Infection—Epirubicin—urinary bladder cancer	0.000438	0.000634	CcSEcCtD
Eplerenone—Cough—Doxorubicin—urinary bladder cancer	0.000436	0.000631	CcSEcCtD
Eplerenone—Shock—Epirubicin—urinary bladder cancer	0.000434	0.000628	CcSEcCtD
Eplerenone—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000432	0.000626	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000429	0.000621	CcSEcCtD
Eplerenone—Skin disorder—Epirubicin—urinary bladder cancer	0.000428	0.00062	CcSEcCtD
Eplerenone—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000426	0.000617	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000426	0.00183	CbGpPWpGaD
Eplerenone—Insomnia—Methotrexate—urinary bladder cancer	0.000426	0.000617	CcSEcCtD
Eplerenone—Chest pain—Doxorubicin—urinary bladder cancer	0.000425	0.000616	CcSEcCtD
Eplerenone—Arthralgia—Doxorubicin—urinary bladder cancer	0.000425	0.000616	CcSEcCtD
Eplerenone—Myalgia—Doxorubicin—urinary bladder cancer	0.000425	0.000616	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—SMC1A—urinary bladder cancer	0.000425	0.00182	CbGpPWpGaD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000422	0.000612	CcSEcCtD
Eplerenone—Discomfort—Doxorubicin—urinary bladder cancer	0.00042	0.000609	CcSEcCtD
Eplerenone—Dyspnoea—Methotrexate—urinary bladder cancer	0.00042	0.000608	CcSEcCtD
Eplerenone—Dyspepsia—Methotrexate—urinary bladder cancer	0.000415	0.0006	CcSEcCtD
Eplerenone—Hypotension—Epirubicin—urinary bladder cancer	0.000412	0.000596	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000409	0.00175	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000408	0.00175	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—TYMP—urinary bladder cancer	0.000407	0.00175	CbGpPWpGaD
Eplerenone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000407	0.000589	CcSEcCtD
Eplerenone—Fatigue—Methotrexate—urinary bladder cancer	0.000406	0.000588	CcSEcCtD
Eplerenone—Infection—Doxorubicin—urinary bladder cancer	0.000405	0.000587	CcSEcCtD
Eplerenone—Pain—Methotrexate—urinary bladder cancer	0.000403	0.000583	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000402	0.000581	CcSEcCtD
Eplerenone—Shock—Doxorubicin—urinary bladder cancer	0.000401	0.000581	CcSEcCtD
Eplerenone—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.0004	0.000579	CcSEcCtD
Eplerenone—Insomnia—Epirubicin—urinary bladder cancer	0.000399	0.000577	CcSEcCtD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000397	0.0017	CbGpPWpGaD
Eplerenone—Skin disorder—Doxorubicin—urinary bladder cancer	0.000396	0.000574	CcSEcCtD
Eplerenone—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000394	0.000571	CcSEcCtD
Eplerenone—Dyspnoea—Epirubicin—urinary bladder cancer	0.000393	0.000569	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000391	0.00168	CbGpPWpGaD
Eplerenone—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000388	0.000562	CcSEcCtD
Eplerenone—Dyspepsia—Epirubicin—urinary bladder cancer	0.000388	0.000562	CcSEcCtD
Eplerenone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000385	0.000558	CcSEcCtD
Eplerenone—Hypotension—Doxorubicin—urinary bladder cancer	0.000381	0.000552	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00038	0.000551	CcSEcCtD
Eplerenone—Fatigue—Epirubicin—urinary bladder cancer	0.00038	0.00055	CcSEcCtD
Eplerenone—Constipation—Epirubicin—urinary bladder cancer	0.000377	0.000546	CcSEcCtD
Eplerenone—Pain—Epirubicin—urinary bladder cancer	0.000377	0.000546	CcSEcCtD
Eplerenone—Body temperature increased—Methotrexate—urinary bladder cancer	0.000372	0.000539	CcSEcCtD
Eplerenone—Abdominal pain—Methotrexate—urinary bladder cancer	0.000372	0.000539	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000372	0.000538	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—ESR2—urinary bladder cancer	0.000371	0.00159	CbGpPWpGaD
Eplerenone—Insomnia—Doxorubicin—urinary bladder cancer	0.000369	0.000534	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—NAT2—urinary bladder cancer	0.000368	0.00158	CbGpPWpGaD
Eplerenone—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000364	0.000526	CcSEcCtD
Eplerenone—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000363	0.000526	CcSEcCtD
Eplerenone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00036	0.000522	CcSEcCtD
Eplerenone—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000359	0.00052	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—GSTP1—urinary bladder cancer	0.000355	0.00152	CbGpPWpGaD
Eplerenone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000352	0.00051	CcSEcCtD
Eplerenone—Fatigue—Doxorubicin—urinary bladder cancer	0.000352	0.000509	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00035	0.0015	CbGpPWpGaD
Eplerenone—Pain—Doxorubicin—urinary bladder cancer	0.000349	0.000505	CcSEcCtD
Eplerenone—Constipation—Doxorubicin—urinary bladder cancer	0.000349	0.000505	CcSEcCtD
Eplerenone—Body temperature increased—Epirubicin—urinary bladder cancer	0.000348	0.000504	CcSEcCtD
Eplerenone—Abdominal pain—Epirubicin—urinary bladder cancer	0.000348	0.000504	CcSEcCtD
Eplerenone—Asthenia—Methotrexate—urinary bladder cancer	0.000338	0.000489	CcSEcCtD
Eplerenone—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000336	0.000487	CcSEcCtD
Eplerenone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000333	0.000483	CcSEcCtD
Eplerenone—Pruritus—Methotrexate—urinary bladder cancer	0.000333	0.000482	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	0.000326	0.0014	CbGpPWpGaD
Eplerenone—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000322	0.000467	CcSEcCtD
Eplerenone—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000322	0.000467	CcSEcCtD
Eplerenone—Diarrhoea—Methotrexate—urinary bladder cancer	0.000322	0.000467	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000322	0.00138	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—RRM2—urinary bladder cancer	0.000318	0.00136	CbGpPWpGaD
Eplerenone—Asthenia—Epirubicin—urinary bladder cancer	0.000316	0.000458	CcSEcCtD
Eplerenone—Pruritus—Epirubicin—urinary bladder cancer	0.000312	0.000452	CcSEcCtD
Eplerenone—Dizziness—Methotrexate—urinary bladder cancer	0.000311	0.000451	CcSEcCtD
Eplerenone—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000307	0.00132	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000303	0.0013	CbGpPWpGaD
Eplerenone—Diarrhoea—Epirubicin—urinary bladder cancer	0.000302	0.000437	CcSEcCtD
Eplerenone—CYP3A7—Metabolism—GSTZ1—urinary bladder cancer	0.000301	0.00129	CbGpPWpGaD
Eplerenone—Vomiting—Methotrexate—urinary bladder cancer	0.000299	0.000434	CcSEcCtD
Eplerenone—Rash—Methotrexate—urinary bladder cancer	0.000297	0.00043	CcSEcCtD
Eplerenone—Dermatitis—Methotrexate—urinary bladder cancer	0.000297	0.00043	CcSEcCtD
Eplerenone—Headache—Methotrexate—urinary bladder cancer	0.000295	0.000427	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—HPGDS—urinary bladder cancer	0.000294	0.00126	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ENO2—urinary bladder cancer	0.000294	0.00126	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000293	0.00126	CbGpPWpGaD
Eplerenone—Asthenia—Doxorubicin—urinary bladder cancer	0.000293	0.000424	CcSEcCtD
Eplerenone—Dizziness—Epirubicin—urinary bladder cancer	0.000291	0.000422	CcSEcCtD
Eplerenone—Pruritus—Doxorubicin—urinary bladder cancer	0.000289	0.000418	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—NCOR1—urinary bladder cancer	0.000286	0.00123	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTT1—urinary bladder cancer	0.000286	0.00122	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTO2—urinary bladder cancer	0.000285	0.00122	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NAT1—urinary bladder cancer	0.000285	0.00122	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000281	0.00121	CbGpPWpGaD
Eplerenone—Vomiting—Epirubicin—urinary bladder cancer	0.00028	0.000406	CcSEcCtD
Eplerenone—Nausea—Methotrexate—urinary bladder cancer	0.00028	0.000405	CcSEcCtD
Eplerenone—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000279	0.000404	CcSEcCtD
Eplerenone—Rash—Epirubicin—urinary bladder cancer	0.000278	0.000402	CcSEcCtD
Eplerenone—Dermatitis—Epirubicin—urinary bladder cancer	0.000278	0.000402	CcSEcCtD
Eplerenone—Headache—Epirubicin—urinary bladder cancer	0.000276	0.0004	CcSEcCtD
Eplerenone—Dizziness—Doxorubicin—urinary bladder cancer	0.00027	0.00039	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—ERCC2—urinary bladder cancer	0.000269	0.00115	CbGpPWpGaD
Eplerenone—Nausea—Epirubicin—urinary bladder cancer	0.000262	0.000379	CcSEcCtD
Eplerenone—CYP3A7—Metabolism—UGT2B7—urinary bladder cancer	0.000261	0.00112	CbGpPWpGaD
Eplerenone—Vomiting—Doxorubicin—urinary bladder cancer	0.000259	0.000375	CcSEcCtD
Eplerenone—Rash—Doxorubicin—urinary bladder cancer	0.000257	0.000372	CcSEcCtD
Eplerenone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000257	0.000372	CcSEcCtD
Eplerenone—Headache—Doxorubicin—urinary bladder cancer	0.000255	0.00037	CcSEcCtD
Eplerenone—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000245	0.00105	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000243	0.00104	CbGpPWpGaD
Eplerenone—Nausea—Doxorubicin—urinary bladder cancer	0.000242	0.000351	CcSEcCtD
Eplerenone—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000238	0.00102	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NQO1—urinary bladder cancer	0.000237	0.00102	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP4B1—urinary bladder cancer	0.000235	0.00101	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.00023	0.000987	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—ESR1—urinary bladder cancer	0.000225	0.000964	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	0.000222	0.000951	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	0.000217	0.000932	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	0.000216	0.000926	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	0.000206	0.000884	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NAT1—urinary bladder cancer	0.000206	0.000884	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—PPARG—urinary bladder cancer	0.000205	0.000879	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000201	0.000861	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTP1—urinary bladder cancer	0.000198	0.000849	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—CREBBP—urinary bladder cancer	0.000197	0.000845	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000192	0.000821	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	0.000188	0.000808	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—TYMS—urinary bladder cancer	0.000184	0.000789	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NCOR1—urinary bladder cancer	0.000182	0.00078	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTM1—urinary bladder cancer	0.000182	0.00078	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GPX1—urinary bladder cancer	0.000174	0.000747	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—TYMP—urinary bladder cancer	0.000173	0.000741	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ERCC2—urinary bladder cancer	0.000171	0.000733	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	0.00017	0.000728	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000165	0.000707	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000163	0.000698	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—MTHFR—urinary bladder cancer	0.000161	0.000689	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	0.00016	0.000687	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NAT2—urinary bladder cancer	0.000156	0.00067	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	0.000156	0.00067	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000152	0.00065	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00015	0.000641	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—RRM2—urinary bladder cancer	0.000135	0.000578	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PPARG—urinary bladder cancer	0.00013	0.000559	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CREBBP—urinary bladder cancer	0.000125	0.000537	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	0.000125	0.000535	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ENO2—urinary bladder cancer	0.000125	0.000535	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—TYMP—urinary bladder cancer	0.000125	0.000535	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	0.000121	0.000519	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—MYC—urinary bladder cancer	0.000117	0.000501	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NAT2—urinary bladder cancer	0.000113	0.000484	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTGS2—urinary bladder cancer	0.000103	0.00044	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	0.000101	0.000433	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NQO1—urinary bladder cancer	0.000101	0.000432	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—RRM2—urinary bladder cancer	9.75e-05	0.000418	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NAT1—urinary bladder cancer	9.58e-05	0.000411	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	9.58e-05	0.000411	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	9.03e-05	0.000387	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ENO2—urinary bladder cancer	9.03e-05	0.000387	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTEN—urinary bladder cancer	8.94e-05	0.000383	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	8.76e-05	0.000376	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	8.76e-05	0.000375	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—EP300—urinary bladder cancer	8.53e-05	0.000366	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	8.4e-05	0.00036	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	7.89e-05	0.000338	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—TYMS—urinary bladder cancer	7.8e-05	0.000335	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	7.71e-05	0.000331	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	7.71e-05	0.000331	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	7.45e-05	0.000319	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GPX1—urinary bladder cancer	7.39e-05	0.000317	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NQO1—urinary bladder cancer	7.28e-05	0.000312	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	7.26e-05	0.000311	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	7.25e-05	0.000311	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	6.82e-05	0.000292	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	6.07e-05	0.00026	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	5.8e-05	0.000249	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—TYMS—urinary bladder cancer	5.64e-05	0.000242	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	5.58e-05	0.000239	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	5.58e-05	0.000239	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PPARG—urinary bladder cancer	5.53e-05	0.000237	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GPX1—urinary bladder cancer	5.34e-05	0.000229	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	5.31e-05	0.000228	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	5.25e-05	0.000225	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	5.24e-05	0.000225	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	4.93e-05	0.000211	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	4.53e-05	0.000194	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	4.35e-05	0.000186	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	4.2e-05	0.00018	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	4.2e-05	0.00018	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	4.07e-05	0.000175	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PPARG—urinary bladder cancer	4e-05	0.000171	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	3.84e-05	0.000165	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTEN—urinary bladder cancer	3.79e-05	0.000163	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—EP300—urinary bladder cancer	3.62e-05	0.000155	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	3.38e-05	0.000145	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	3.14e-05	0.000135	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.82e-05	0.000121	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTEN—urinary bladder cancer	2.74e-05	0.000118	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.62e-05	0.000112	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—EP300—urinary bladder cancer	2.61e-05	0.000112	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	2.59e-05	0.000111	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	2.59e-05	0.000111	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.48e-05	0.000106	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2.44e-05	0.000105	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.29e-05	9.82e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.86e-05	7.97e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.78e-05	7.65e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.46e-05	6.27e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.27e-05	5.47e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.22e-05	5.21e-05	CbGpPWpGaD
